Igor Rukhman

This inventor holds 19 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Teva Pharmaceutical Industries Limited, Svc Pharma LP, Purdue Pharma L.p.. Active years: 2005-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Igor Rukhman. Retrieved from https://idiyas.com/inventor/igor-rukhman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 4)

% Patents Active = 26.3

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 59(Granted Patents)

Location History:

Technion, IL (2006 - 2008)
Haifa, IL (2005 - 2011)
Yokneam, IL (2013 - 2017)
Yokneam Illit, IL (2020)

Company Filing History:

11 out of 505

Teva Pharmaceutical Industries Limited

Finetech Pharmaceutical Ltd

patent

6. 1 out of 9

Opko Pharmaceuticals, LLC

patents

Years Active: 2005-2020

Loading Chart...

Areas of Expertise:

Heptasulfated Disaccharides

Bimatoprost Crystalline Form

Irbesartan Synthesis

Valsartan Preparation

Losartan Polymorphs

Bioavailability

Chemical Intermediates

Pharmaceutical Polymorphs

Tetrazole Compounds

Synthesis Methods

Crystalline Forms

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10829509 - Pure heptasulfated disaccharides having improved oral bioavailability (2020-11-10),

2. 9744151 - [object Object] (2017-08-29),

3. 9675581 - [object Object] (2017-06-13),

4. 9278083 - [object Object] (2016-03-08),

5. 8937097 - [object Object] (2015-01-20),

6. 8383842 - [object Object] (2013-02-26),

7. 7947740 - Bimatoprost crystalline form I (2011-05-24),

8. 7838683 - Synthesis of irbesartan (2010-11-23),

9. 7378531 - Process for the preparation of valsartan (2008-05-27),

10. 7332612 - Amorphous and crystalline forms of losartan potassium and process for their preparation (2008-02-19),

11. 7312340 - Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one (2007-12-25),

12. 7301035 - Intermediates for the synthesis of irbesartan (2007-11-27),

13. 7227026 - Synthesis of irbesartan (2007-06-05),

14. 7217825 - Synthesis of irbesartan (2007-05-15),

15. 7199144 - Process for the preparation of valsartan and intermediates thereof (2007-04-03),

Title: Igor Rukhman - Pioneering Inventor from Haifa, Israel

Introduction: Igor Rukhman is a distinguished inventor hailing from Haifa, Israel, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Igor Rukhman holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: With a career spanning over two decades, Igor Rukhman has worked with top research institutions and leading tech companies, consistently pushing the boundaries of what is possible in the world of inventions.

Collaborations: Throughout his career, Igor Rukhman has collaborated with renowned scientists, engineers, and inventors from around the globe, fostering a culture of innovation and knowledge-sharing.

Conclusion: Igor Rukhman's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of inventions, inspiring the next generation of inventors to dream big and think outside the box.

Profile summary based on public USPTO records.